148
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study

, ORCID Icon, , &
Pages 675-685 | Published online: 21 Apr 2021

References

  • Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269. doi:10.1038/s41586-020-2008-332015508
  • Awadasseid A, Wu Y, Tanaka Y, et al. Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China. Int J Biol Sci. 2020;16:1846–1860. doi:10.7150/ijbs.4501832398954
  • Weekly operational update on COVID-19. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update. Accessed 119, 2021.
  • Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280.e8. doi:10.1016/j.cell.2020.02.05232142651
  • Hundt MA, Deng Y, Ciarleglio MM, et al. Abnormal liver tests in COVID-19: a retrospective observational cohort study of 1827 patients in a major U.S. hospital network. Hepatology. 2020;72(4):1169–1176. doi:10.1002/hep.3148732725890
  • Cai Q, Huang D, Yu H, et al. COVID-19: abnormal liver function tests. J Hepatol. 2020;73:566–574. doi:10.1016/j.jhep.2020.04.00632298767
  • Fan Z, Chen L, Li J, et al. Clinical features of COVID-19-related liver functional abnormality. Clin Gastroenterol Hepatol. 2020;18:1561–1566. doi:10.1016/j.cgh.2020.04.00232283325
  • Zhang Y, Zheng L, Liu L, et al. Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020;40:2095–2103. doi:10.1111/liv.1445532239796
  • Lei F, Liu YM, Zhou F, et al. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology. 2020;72:389–398. doi:10.1002/hep.3130132359177
  • National Health Commision of the People’s Republic of China. New coronavirus pneumonia prevention and control program (the fifth edition).. 2020. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml. Accessed 25, 2020.
  • Rich JT, Neely JG, Paniello RC, et al. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg. 2010;143:331–336. doi:10.1016/j.otohns.2010.05.00720723767
  • Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017–1032. doi:10.1038/s41591-020-0968-332651579
  • Sultan S, Altayar O, Siddique SM, et al. AGA Institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020;159:320–334.e27. doi:10.1053/j.gastro.2020.05.00132407808
  • Cholankeril G, Podboy A, Aivaliotis VI, et al. High prevalence of concurrent gastrointestinal manifestations in patients with severe acute respiratory syndrome Coronavirus 2: early experience from California. Gastroenterology. 2020;159(2):775–777. doi:10.1053/j.gastro.2020.04.00832283101
  • Hajifathalian K, Krisko T, Mehta A, et al. Gastrointestinal and hepatic manifestations of 2019 novel coronavirus disease in a large cohort of infected patients from New York: clinical implications. Gastroenterology. 2020;159:1137–1140.e2. doi:10.1053/j.gastro.2020.05.01032389667
  • Singh S, Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a Multicenter Research Network Study. Gastroenterology. 2020;159:768–771.e3.32376408
  • Phipps MM, Barraza LH, LaSota ED, et al. Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large US cohort. Hepatology. 2020;72(3):807–817. doi:10.1002/hep.3140432473607
  • Pirola CJ, Sookoian S. COVID-19 and ACE2 in the liver and gastrointestinal tract: putative biological explanations of sexual dimorphism. Gastroenterology. 2020;159:1620–1621. doi:10.1053/j.gastro.2020.04.050
  • Jothimani D, Venugopal R, Abedin MF, et al. COVID-19 and the liver. J Hepatol. 2020;73:1231–1240. doi:10.1016/j.jhep.2020.06.00632553666
  • Yip TC, Lui GC, Wong VW, et al. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19. Gut. 2020;70(4):733–742. doi:10.1136/gutjnl-2020-32172632641471
  • Huang H, Chen S, Li H, et al. The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan. Aliment Pharmacol Ther. 2020. doi:10.1111/apt.15962
  • Saini RK, Saini N, Ram S, et al. COVID-19 associated variations in liver function parameters: a retrospective study. Postgrad Med J. 2020. doi:10.1136/postgradmedj-2020-138930
  • Shi S, Wang F, Li J, et al. The effect of Chinese herbal medicine on digestive system and liver functions should not be neglected in COVID-19: an updated systematic review and meta-analysis. IUBMB Life. 2021. doi:10.1002/iub.2467
  • Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:667–678. doi:10.1016/S2468-1253(20)30126-632405603
  • Hormati A, Ghadir MR, Saeidi M, et al. Dysentery as a rare GI symptom found in COVID-19 patients. Gastroenterol Hepatol. 2021;44:31–34. doi:10.1016/j.gastrohep.2020.06.00532711958
  • Hormati A, Ghadir MR, Saeidi M, et al. Hepatic involvement as hyperbilirubinemia in patients with COVID-19: case series from Iran. Infect Disord Drug Targets. 2021;21:. doi:10.2174/1871526521666210218201601
  • Hormati A, Ghadir MR, Zamani F, et al. Preventive strategies used by GI physicians during the COVID-19 pandemic. New Microbes New Infect. 2020;35:100676. doi:10.1016/j.nmni.2020.10067632292589
  • Ali N, Hossain K. Liver injury in severe COVID-19 infection: current insights and challenges. Expert Rev Gastroenterol Hepatol. 2020;14:879–884. doi:10.1080/17474124.2020.179481232649840